Sun Pharma has acquired all outstanding shares of Checkpoint at a price of $4.10 per share in cash, without interest, plus one non-tradable contingent value right (CVR) per share representing the ...

The transaction was finalized on May 30, 2025, with Checkpoint Therapeutics, valued at approximately $357 million by market capitalization, becoming a wholly-owned subsidiary of Sun Pharma.

Sun Pharmaceutical Industries on Friday announced the successful completion of its acquisition of Checkpoint Therapeutics, Inc. (Checkpoint), an immunotherapy and targeted oncology company.As part ...

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715 (together with its subsidiaries and/or associated companies, "Sun Pharma")) today announced the ...

Sun Pharma has acquired all outstanding shares of Checkpoint at a price of $4.10 per share in cash, without interest, plus one non-tradable contingent value right (CVR) per share representing the ...

Potential Positives. The acquisition of Checkpoint Therapeutics by Sun Pharmaceutical Industries is expected to enhance patient access to the FDA-approved therapy UNLOXCYT™, thereby potentially ...

Sun Pharma has acquired all outstanding shares of Checkpoint at a price of $4.10 per share in cash, ... About Sun Pharmaceutical Industries Limited (CIN - L24230GJ1993PLC019050) ...

Sun Pharma has acquired all outstanding shares of Checkpoint at a price of $4.10 per share in cash, ... About Sun Pharmaceutical Industries Limited (CIN - L24230GJ1993PLC019050) ...

The merger arrives as Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)’s market cap stands at $370.71 million. With the deal valued at $416 million, the premium paid by Sun Pharma signals confidence ...

Sun Pharma has agreed a takeover deal with US biotech Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running low on cash. The Indian pharma group ...